ABSTRACT

This unique handbook (60 chapters) examines the entire "product life cycle," from the creation of nanomedical products to their final market introduction. While focusing on critical issues relevant to nanoproduct development and translational activities, it tackles topics such as regulatory science, patent law, FDA law, ethics, personalized medicin

part |2 pages

Section I: Law, Business, and Commercialization

chapter 8|18 pages

Technology Transfer: An Overview

chapter 9|26 pages

Licensing Issues in Nanotechnology

chapter 15|20 pages

Nanotechnology Implications for Labor

part |2 pages

Section II: Regulatory Issues and Nanogovernance

chapter 18|16 pages

EU Regulation of Nanobiotechnology

chapter 19|12 pages

Regulating Nanomedicine

part |2 pages

Section III: Health, Safety, Risk, and Biological Interactions

chapter 31|26 pages

In vitro Risk Assessment of Nanoparticles

chapter 32|64 pages

Biological Responses to Nanoparticles

chapter 33|14 pages

Cell and Protein Interactions with Diamond

chapter 36|28 pages

Nanotoxicology: Focus on Nanomedicine

part |2 pages

Section IV: Future Implications, Ethics, Perspectives, and Editorials

chapter 39|36 pages

Future Concepts in Nanomedicine

chapter 42|26 pages

Nanomedicine: Ethical Considerations

chapter 44|10 pages

Nanomedicine: Shadow and Substance